Literature DB >> 17332509

Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.

Anjali Shiras1, Sivarajan T Chettiar, Varsha Shepal, Ganeshkumar Rajendran, G Rajendra Prasad, Padma Shastry.   

Abstract

The presence of a CD133+/nestin+ population in brain tumors suggests that a normal neural stem cell may be the cell of origin for gliomas. We have identified human CD133-positive NSCs from adult glioma tissue and established them as long-term in vitro cultures human neuroglial culture (HNGC)-1. Replicative senescence in HNGC-1 led to a high level of genomic instability and emergence of a spontaneously immortalized clone that developed into cell line HNGC-2 with features of cancer stem cells (CSCs), which include the ability for self-renewal and the capacity to form CD133-positive neurospheres and develop intracranial tumors. The data from our study specify an important role of genomic instability in initiation of transformed state as well as its progression into highly tumorigenic CSCs. The activated forms of Notch and Hes isoforms were expressed in both non-neoplastic neural stem cells and brain tumor stem cells derived from it. Importantly, a significant overexpression of these molecules was found in the brain tumor stem cells. These findings suggest that this model comprised of HNGC-1 and HNGC-2 cells would be a useful system for studying pathways involved in self-renewal of stem cells and their transformation to cancer stem cells. Disclosure of potential conflicts of interest is found at the end of this article.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332509     DOI: 10.1634/stemcells.2006-0585

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  47 in total

Review 1.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 2.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 3.  Glioblastoma cancer stem cells: Biomarker and therapeutic advances.

Authors:  Kelli B Pointer; Paul A Clark; Michael Zorniak; Bahauddeen M Alrfaei; John S Kuo
Journal:  Neurochem Int       Date:  2014-03-19       Impact factor: 3.921

Review 4.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

Review 5.  Mutant ATRX: uncovering a new therapeutic target for glioma.

Authors:  Santiago Haase; María Belén Garcia-Fabiani; Stephen Carney; David Altshuler; Felipe J Núñez; Flor M Méndez; Fernando Núñez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

6.  YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation.

Authors:  Thomas Rauen; Ute Raffetseder; Björn C Frye; Sonja Djudjaj; Philipp J T Mühlenberg; Frank Eitner; Urban Lendahl; Jürgen Bernhagen; Steven Dooley; Peter R Mertens
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

Review 7.  Stem cell-based therapies for spinal cord injury.

Authors:  Rishi S Nandoe Tewarie; Andres Hurtado; Ronald H Bartels; Andre Grotenhuis; Martin Oudega
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

8.  Platelet-released growth factors can accelerate tenocyte proliferation and activate the anti-oxidant response element.

Authors:  M Tohidnezhad; D Varoga; C J Wruck; L O Brandenburg; A Seekamp; M Shakibaei; T T Sönmez; Thomas Pufe; S Lippross
Journal:  Histochem Cell Biol       Date:  2011-04-08       Impact factor: 4.304

9.  Co-graft of allogeneic immune regulatory neural stem cells (NPC) and pancreatic islets mediates tolerance, while inducing NPC-derived tumors in mice.

Authors:  Raffaella Melzi; Barbara Antonioli; Alessia Mercalli; Manuela Battaglia; Andrea Valle; Stefano Pluchino; Rossella Galli; Valeria Sordi; Emanuele Bosi; Gianvito Martino; Ezio Bonifacio; Claudio Doglioni; Lorenzo Piemonti
Journal:  PLoS One       Date:  2010-04-27       Impact factor: 3.240

10.  Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.

Authors:  Ryan Morrison; Stephen M Schleicher; Yunguang Sun; Kenneth J Niermann; Sungjune Kim; Daniel E Spratt; Christine H Chung; Bo Lu
Journal:  J Oncol       Date:  2010-10-12       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.